Inflammatix
In Brief This Week: Labcorp; Roche; Bio-Techne; Co-Diagnostics; Burning Rock; Inflammatix; More
News items for the week of March 24, 2025.
Roche, Abbott, Inflammatix, Paige, Others Gain 510(k) Clearances in January
The US Food and Drug Administration in January granted 510(k) marketing clearances for a 30-minute sepsis test, digital pathology software, and various infectious disease tests
Top Five Articles on 360Dx Last Week: Roche STI Test Gains Regulatory Clearance; More
Last week, readers were most interested in a story about Roche gaining FDA clearance and CLIA waiver for its STI point-of-care test.
The molecular test is used to differentiate bacterial infections, viral infections, and noninfectious disease and to assess the risk that patients will develop severe illness.
Sepsis Test Developers Progress on Commercialization, Market Approvals of Rapid Tests During 2024
Premium
Firms in the space advanced solutions to stratify sepsis patients and accelerated time-to-results to find out the cause of infections.